PAUL BADER: Open Payments
NPI 1407484900 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 86 payments from 17 companies in 2025. Trend: 2023 $1,918 · 2024 $1,847 · 2025 $1,479
Food & beverage: $1,329Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $278 |
| ABBVIE INC. | 21 | $278 |
| PFIZER INC. | 13 | $168 |
| GlaxoSmithKline, LLC. | 10 | $151 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Lilly USA, LLC | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 6 | $57 |
| Exact Sciences Corporation | 3 | $48 |
Products named: Ozempic, XYWAV, VRAYLAR, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY, XIFAXAN, ELIQUIS.
Industry payments across TN — which companies pay providers there.
